Modelling the healthcare costs of skin cancer in South Africa
| Autor: | Thomas M. Elliott, Louisa G. Gordon, Caradee Y. Wright, W I Visser, Nicola Deghaye |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Skin Neoplasms Cost estimate Total cost Ultraviolet Rays Health administration 030207 dermatology & venereal diseases 03 medical and health sciences South Africa 0302 clinical medicine Environmental health Squamous cell carcinoma Health care medicine Skin cancer Humans Activity-based costing Melanoma Gynecology Population statistics business.industry Health Policy Public health Incidence Cost-of-illness Health Care Costs Middle Aged medicine.disease Carcinoma Basal Cell 030220 oncology & carcinogenesis Basal cell carcinoma Carcinoma Squamous Cell Female Public Health business Research Article |
| Zdroj: | BMC Health Services Research |
| ISSN: | 1472-6963 |
| Popis: | Background Skin cancer is a growing public health problem in South Africa due to its high ambient ultraviolet radiation environment. The purpose of this study was to estimate the annual health system costs of cutaneous melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) in South Africa, incorporating both the public and private sectors. Methods A cost-of-illness study was used to measure the economic burden of skin cancer and a ‘bottom-up’ micro-costing approach. Clinicians provided data on the patterns of care and treatments while national costing reports and clinician fees provided cost estimates. The mean costs per melanoma and per SCC/BCC were extrapolated to estimate national costs using published incidence data and official population statistics. One-way and probabilistic sensitivity analyses were undertaken to address the uncertainty of the parameters used in the model. Results The estimated total annual cost of treating skin cancers in South Africa were ZAR 92.4 million (2015) (or US$15.7 million). Sensitivity analyses showed that the total costs could vary between ZAR 89.7 to 94.6 million (US$15.2 to $16.1 million) when melanoma-related variables were changed and between ZAR 78.4 to 113.5 million ($13.3 to $19.3 million) when non-melanoma-related variables were changed. The primary drivers of overall costs were the cost of excisions, follow-up care, radical lymph node dissection, cryotherapy and radiation therapy. Conclusion The cost of managing skin cancer in South Africa is sizable. Since skin cancer is largely preventable through improvements to sun-protection awareness and skin cancer prevention programs, this study highlights these healthcare resources could be used for other pressing public health problems in South Africa. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|